Healio: Lung cancer survivors at risk for non-lung secondary cancer years after definitive therapy Lung cancer survivors at risk for non-lung secondary cancer years after definitive therapy Please provide your email address to receive an email when new articles are posted on . Non-lung secondary cancers can develop in survivors of lung cancer years after completion of definitive therapy. Patients with a history of breast, kidney, lung and several other types of cancer who undergo solid organ transplant have a significantly higher risk for developing a second malignancy at the same ...

Understanding the Context

Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data. AOL: Severe Covid or flu may raise the risk of lung cancer risk years later Severe covid and flu infections may raise the risk of developing lung cancer years later, researchers at the University of Virginia said. A study conducted in both mice and humans showed that subjects ... Severe Covid or flu may raise the risk of lung cancer risk years later Cancer SIFs associated with increased risk for extrapulmonary cancer diagnosis in the year following an LDCT lung cancer screening exam.

Key Insights

ascopubs.org: Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of Biomarkers Optimizing Lung Cancer Screening With Risk Prediction: Current Challenges and the Emerging Role of Biomarkers Severe respiratory infections, caused by COVID-19 or even certain flu strains, could leave lasting damage in the lungs, increasing the long-term risk of cancer. This observation comes from ... News Medical: Severe COVID and flu infections increase risk of lung cancer